Thursday, April 9, 2026

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

How a 2-Cent Sugar Tax Could Save $4.5 Billion in Healthcare Costs: California’s Bold Move

A sugar-sweetened beverage tax in California could cut obesity cases and save $4.5 billion in healthcare costs over ten years.

How the U.S.-Korea Joint Training at NTC Enhances Combat Readiness: Key Takeaways

U.S. and South Korean troops conducted joint training at NTC, enhancing combat skills and interoperability in challenging conditions.

Tag: Batoclimab

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.